University of California San Francisco
Give to UCSF
A new AI-based model can predict where the most common malignant brain cancer is most likely to return after initial surgery, potentially giving doctors a chance to treat it before it becomes visible on MRI.
Four UCSF faculty members will each receive over $2 million in total over the next five years as members of the 2026 class of New Innovators in the Common Fund’s High-Risk, High-Reward Research (HRHRR) program.
How does your brain decide whether to hit “send” on a risky email or delete the draft? Two neighboring parts of it argue with each other until one overrules the other. Researchers created a video game to see what players’ brains were doing while making risk-reward decisions.
“The cognition crisis is not just a clinical problem. It’s a problem for our species.” UCSF scientists on what screens are doing to our minds — and how to get your focus back.
The upsurge in Parkinson's cases has been described as reaching pandemic levels. Caroline Tanner, MD, PhD, discusses her research, which explains why cases are rising, and what we can do to reduce our risk or slow progression.
MRIs are among the most accurate imaging tests used to diagnose brain tumors, and MRI-based monitoring of tumors guides critical treatment decisions. The clinical standard for measuring tumors
Saxitoxin, a neurotoxin released in algal blooms, has killed many people on the West Coast who've gathered shellfish that were exposed to it. The poison has also been developed as a chemical weapon. There is no antidote, yet — but it does exist.
UCSF Health today announced a $170,000 investment in start-up funding to partner with Foothill College to develop a new two-year Neurodiagnostic Technologist (NDT) program. This landmark initiative
A study will test new drugs for early disease in an effort to prevent the buildup of toxic tau tangles that lead to cognitive decline.
UCSF researchers are using tiny "mini-organs" to model disease, personalize treatment, and understand human development. They are also addressing the limitations holding the field back: giving organoids a vascular system and making organoids reproducible.
UCSF expert Kristine Yaffe, MD, explores how targeting modifiable risk factors—like sleep and exercise—can actively protect your aging brain.
UC San Francisco researchers have developed a new form of deep brain stimulation (DBS) that adjusts in real time as a person walks, helping to improve gait and reduce falls in people with Parkinson’s
Ethan Winkler, who studies aneurysms, discovered a dynamic between cells in the brain's blood vessels that explains why aneurysms burst. The findings describe a "life cycle" of an aneurysm and will likely change how physicians assess the risk for rupture and opportunities for personalizing treatment.
About 6% of asymptomatic adults have a biomarker for Alzheimer's disease and are already showing very subtle signs of the disease that would not come to light in a standard cognitive test.
A team at UCSF developed a multitask deep learning framework that can effectively predict Alzheimer’s disease diagnosis, cognitive scores, and future cognitive decline using only baseline MRI and demographics.
In the last few years, progress has been made in the fight against Alzheimer’s disease with a class of therapies called anti-amyloid antibodies (anti-Aβ). These anti-Aβ therapies, like lecanumab
Multiple clinical trials have shown that GLP-1s are safe and effective for patients with obesity, diabetes and cardiovascular conditions. New evidence shows that the drugs may also protect against neurological diseases, like dementia, Parkinson's, and substance use disorder.
A large team of scientists, found that a single dose of psilocybin created positive changes in the brain and well-being, one hour and one month after administration.
Epilepsy physicians Jon Kleen and Eddie Chang used high-resolution technology to see how cognition is disrupted in people with epilepsy and predict when it will occur. The new view points the way to being able to fend of these disruptions.
UCSF's Cherry Leung, associate professor of community health systems with the UC San Francisco School of Nursing, researches the gut-brain axis as a potential adjunct therapy for improving adolescent mental health.
Freeze-dried human platelets could be used as a "molecular tourniquet" for brain bleeds in the minutes to hours after a traumatic brain injury, according to a UCSF team led by Shibani Pati. The scientists envision stocking ambulances and EDs with the product.
UCSF research shows psychedelics like psilocybin may treat depression, Parkinson’s, and addiction, offering new hope in clinical trials.
Rajiv Sethi, MD, PhD, has been appointed chief of the UCSF Division of Orthopaedic Spine Surgery, one of the nation’s premier spine programs. He has also been named co-director of the UCSF Spine
UCSF researchers are studying how climate change fuels toxic algal blooms, partnering with global and tribal communities to monitor health risks and protect food security.
Researchers discover that the nerve cells that make us uniquely human are also uniquely vulnerable to dying during the waves of inflammation that occur in multiple sclerosis.
A new study traces the molecular pathway connecting the gut immune system to the brain during a parasitic infection, explaining how the immune system triggers a loss of appetite.
